<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	>
<channel>
	<title>Comments on: Michael Crichton: Next Review</title>
	<atom:link href="http://www.brianberliner.com/2007/01/04/michael-crichton-next-review/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.brianberliner.com/2007/01/04/michael-crichton-next-review/</link>
	<description>This is your brain on: Venture Capital and Technology</description>
	<pubDate>Fri, 25 Jul 2008 14:37:22 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.6-bleeding2</generator>
		<item>
		<title>By: 5AM Ventures Closes $150M Fund II - I&#8217;m In! at Brian Berliner&#8217;s Brain</title>
		<link>http://www.brianberliner.com/2007/01/04/michael-crichton-next-review/#comment-6589</link>
		<dc:creator>5AM Ventures Closes $150M Fund II - I&#8217;m In! at Brian Berliner&#8217;s Brain</dc:creator>
		<pubDate>Mon, 08 Jan 2007 09:30:00 +0000</pubDate>
		<guid isPermaLink="false">http://www.brianberliner.com/2007/01/04/michael-crichton-next-review/#comment-6589</guid>
		<description>[...] I always invest in the market. The biotechnology and medical devices markets are focused on bringing life-changing advances to mankind. These are big-money markets today, and the next 10 years will see some amazing breakthroughs (pay no attention to my review of Next). Early-stage investors, like 5AM Ventures, are investing at the right time to see some seriously big returns. At $150M, it&#8217;s a relatively small fund for biotech (which, I think is to their advantage), but the likes of John, Andy, and Scott have the knowledge and contacts to find and win the right to invest and grow the best companies. In essence, a smaller fund focused on early-stage investments with a well-connected team in a booming and liquid sector means, to me, that their chance for one or two very big wins are higher than most. [...]</description>
		<content:encoded><![CDATA[<p>[...] I always invest in the market. The biotechnology and medical devices markets are focused on bringing life-changing advances to mankind. These are big-money markets today, and the next 10 years will see some amazing breakthroughs (pay no attention to my review of Next). Early-stage investors, like 5AM Ventures, are investing at the right time to see some seriously big returns. At $150M, it&#8217;s a relatively small fund for biotech (which, I think is to their advantage), but the likes of John, Andy, and Scott have the knowledge and contacts to find and win the right to invest and grow the best companies. In essence, a smaller fund focused on early-stage investments with a well-connected team in a booming and liquid sector means, to me, that their chance for one or two very big wins are higher than most. [...]</p>
]]></content:encoded>
	</item>
</channel>
</rss>

<!-- Dynamic Page Served (once) in 0.443 seconds -->
